Lisa Holle, PharmD, BCOP, FHOPA, University of Connecticut School of Pharmacy, Storrs, CT, highlights data coming from a study looking at methods to improve patient understanding of adverse events in cancer, which received an International Society of Oncology Pharmacy Practitioners (ISOPP) Research Grant. Dr Holle also describes the next steps for this exciting research. This interview took place at the ISOPP Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.